Novel and efficient method for the reconstruction of adenoviruses through isothermal assembly and its potential applications.

Ke Wen, Matthew D Resch, Ryan Mazboudi, Hannah Mulhall Maasz, Jose M Galarza
{"title":"Novel and efficient method for the reconstruction of adenoviruses through isothermal assembly and its potential applications.","authors":"Ke Wen,&nbsp;Matthew D Resch,&nbsp;Ryan Mazboudi,&nbsp;Hannah Mulhall Maasz,&nbsp;Jose M Galarza","doi":"10.3389/fmedt.2023.1095198","DOIUrl":null,"url":null,"abstract":"<p><p>Adenovirus based vectors are useful tools for vaccine development, gene therapy, and oncolytic virotherapy. Here we describe a novel approach for the genetic engineering of any portion of the adenovirus genome and the reconstruction of either fully replication competent or defective virions. This innovative strategy is rapid, effective and suitable for the manipulation of the entire genome broadening the spectrum of potential applications for the adenovirus system. Our strategy involved insertion of restriction enzyme recognition sequences absent in the native virus into the termini of the adenovirus genome in order to facilitate recovery. These restriction enzyme sites, together with the two inverted terminal repeats and packaging sequences, were synthesized and then subcloned into the pBR322 vector. The remaining internal portion of the adenovirus genome was separated and amplified <i>via</i> PCR into six segments, of which groups of two were joined together by PCR and then subcloned into pBR322 plasmids. During the PCR reaction, an overlap of 30-40 bp was added to the termini of the adjacent fragments, allowing for the subsequent isothermal assembly and correct orientation of all fragments. This approach allows for the genetic modification of each genomic fragment according to the specific research goals, (e.g., deletion, substitution, addition, etc.) To recreate the entire viral genome, the four engineered fragments (each comprised of two adenovirus genomic sections) as well as the pBR322 backbone, were reassembled into a single construct utilizing an isothermal assembly reaction. Finally, the reassembled plasmid containing the entire genome was linearized and transfected into HEK293 cells to recover the complete reconstructed adenoviral vector. Using this approach, we have successfully generated two recombinant reporter adenoviruses, one of human adenovirus serotype 14 and another of serotype 55. The E3 region was replaced by the reporter genes (GFP and Luciferase) to visualize and track the recovery process. Subsequent infection of A549 cells with these reconstructed adenovirus vectors demonstrated that they were replication competent. This method shortens the viral reconstruction process because the one-step isothermal assembly requires less than 4 days, and recombinant adenovirus recovery occurs within 10 days. This new method allows for single or multiple genetic modifications within any portion of the viral genome and can be used to construct or manipulate any adenovirus whose complete genome sequence is known.</p>","PeriodicalId":12599,"journal":{"name":"Frontiers in Medical Technology","volume":"5 ","pages":"1095198"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909595/pdf/","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medical Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fmedt.2023.1095198","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Adenovirus based vectors are useful tools for vaccine development, gene therapy, and oncolytic virotherapy. Here we describe a novel approach for the genetic engineering of any portion of the adenovirus genome and the reconstruction of either fully replication competent or defective virions. This innovative strategy is rapid, effective and suitable for the manipulation of the entire genome broadening the spectrum of potential applications for the adenovirus system. Our strategy involved insertion of restriction enzyme recognition sequences absent in the native virus into the termini of the adenovirus genome in order to facilitate recovery. These restriction enzyme sites, together with the two inverted terminal repeats and packaging sequences, were synthesized and then subcloned into the pBR322 vector. The remaining internal portion of the adenovirus genome was separated and amplified via PCR into six segments, of which groups of two were joined together by PCR and then subcloned into pBR322 plasmids. During the PCR reaction, an overlap of 30-40 bp was added to the termini of the adjacent fragments, allowing for the subsequent isothermal assembly and correct orientation of all fragments. This approach allows for the genetic modification of each genomic fragment according to the specific research goals, (e.g., deletion, substitution, addition, etc.) To recreate the entire viral genome, the four engineered fragments (each comprised of two adenovirus genomic sections) as well as the pBR322 backbone, were reassembled into a single construct utilizing an isothermal assembly reaction. Finally, the reassembled plasmid containing the entire genome was linearized and transfected into HEK293 cells to recover the complete reconstructed adenoviral vector. Using this approach, we have successfully generated two recombinant reporter adenoviruses, one of human adenovirus serotype 14 and another of serotype 55. The E3 region was replaced by the reporter genes (GFP and Luciferase) to visualize and track the recovery process. Subsequent infection of A549 cells with these reconstructed adenovirus vectors demonstrated that they were replication competent. This method shortens the viral reconstruction process because the one-step isothermal assembly requires less than 4 days, and recombinant adenovirus recovery occurs within 10 days. This new method allows for single or multiple genetic modifications within any portion of the viral genome and can be used to construct or manipulate any adenovirus whose complete genome sequence is known.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
等温组装重建腺病毒的新方法及其应用前景。
腺病毒载体是疫苗开发、基因治疗和溶瘤病毒治疗的有用工具。在这里,我们描述了一种新的方法,用于腺病毒基因组的任何部分的基因工程和完全复制或有缺陷的病毒粒子的重建。这种创新的策略是快速、有效和适用于整个基因组的操作,拓宽了腺病毒系统的潜在应用范围。我们的策略包括将原生病毒中缺失的限制性内切酶识别序列插入腺病毒基因组的末端,以促进恢复。这些限制性内切酶位点与两个末端重复序列和包装序列一起合成,然后亚克隆到pBR322载体中。将腺病毒基因组的剩余内部部分分离并通过PCR扩增成6个片段,其中2个片段通过PCR连接在一起,然后亚克隆到pBR322质粒中。在PCR反应中,在相邻片段的末端添加了30-40 bp的重叠,允许随后的等温组装和所有片段的正确定向。这种方法允许根据特定的研究目标对每个基因组片段进行遗传修饰,(例如,删除,替换,添加等)为了重建整个病毒基因组,利用等温组装反应将四个工程片段(每个片段由两个腺病毒基因组部分组成)以及pBR322主干重新组装成一个结构体。最后,将重组的含全基因组的质粒线性化,转染到HEK293细胞中,恢复完整的重组腺病毒载体。利用这种方法,我们成功地生成了两种重组报告腺病毒,一种是人腺病毒血清型14,另一种是血清型55。E3区域被报告基因(GFP和荧光素酶)取代,以可视化和跟踪恢复过程。随后用这些重建的腺病毒载体感染A549细胞,表明它们具有复制能力。该方法缩短了病毒重建过程,一步等温组装需要不到4天,重组腺病毒在10天内恢复。这种新方法允许在病毒基因组的任何部分进行单次或多次遗传修饰,并可用于构建或操纵任何已知完整基因组序列的腺病毒。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Case Report: The effect of automated manual lymphatic drainage therapy on lymphatic contractility in 4 distinct cases Detection of natural autoimmunity to ghrelin in diabetes mellitus Ensuring safety and efficacy in combination products: regulatory challenges and best practices Augmented reality-based software (Echo-QR) for guiding the echographic probe toward the acoustic window: a pilot study Ethical considerations in the regulation and use of herbal medicines in the European Union
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1